参考文献/References:
[1] CUI Xinle, SNAPPER C M. Epstein Barr Virus: Development of vaccines and immune cell therapy for EBV-associated diseases[J]. Front Immunol, 2021, 12:734471.
[2] NISHIKAWA J, IIZASA H, YOSHIYAMA H, et al. Clinical importance of Epstein-Barr virus-associated gastric cancer[J]. Cancers, 2018, 10(6): 167.
[3] TANGYE S G. Genetic susceptibility to EBV infection: insights from inborn errors of immunity[J]. Human Genetics, 2020, 139(6/7): 885-901.
[4] TORRES K, LANDEROS N, WICHMANN I A, et al. EBV miR-BARTs and human LncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(4): 166049.
[5] ?IDOVEC L S, MATULI? M, GR?KOVI? P, et al. MiRNAs：EBV mechanism for escaping host’s immune response and supporting tumorigenesis[J].Pathogens, 2020, 9(5): 353.
[6] ZHENG Xiang, WANG Jia, WEI Lingyu, et al. Epstein-Barr virus microRNA miR-BART5-3p inhibits p53 expression[J]. Journal of Virology, 2018, 92(23): e01022-18.
[7] WANG Jia, ZHENG Xiang, QIN Zailong, et al. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer[J].Journal of Biological Chemistry, 2019, 294(13): 4854-4866.
[8] SONG Yali, LI Xiaoling, ZENG Zhaoyang, et al. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1[J]. Oncotarget, 2016, 7(24): 36783-36799.
[9] MIN K, LEE S K. EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1[J].International Journal of Biological Sciences, 2019, 15(3): 657-667.
[10] SONG Yali, LI Qiao, LIAO Shan, et al. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelialmesenchymal transition via targeting FOXP1 in gastric cancer [J]. Virology, 2020, 548: 6-16.
[11] YOON J H, MIN K, LEE S K. Epstein-Barr virus miR-BART17-5p promotes migration and Anchorage-Independent growth by targeting kruppel-like factor 2 in gastric cancer[J]. Microorganisms, 2020, 8(2): 258.
[12] MIN K, KIM J Y, LEE S K. Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2[J]. International Journal of Biological Sciences, 2020, 16(4): 694-707.
[13] LIU Juanjuan, ZHANG Yan, LIU Wen, et al. MiRBART1-5p targets core 2β-1,6-acetylglucosaminyltransferase GCNT3 to inhibit cell proliferation and migration in EBV-associated gastric cancer [J]. Virology, 2020, 541: 63-74.
[14] SHI Duo, ZHANG Yan, MAO Tao, et al. MiRBART2-3p targets Unc-51-like kinase 1 and inhibits cell autophagy and migration in Epstein-Barr virusassociated gastric cancer [J]. Virus Research, 2021, 305: 198567.
[15] WANG Hanqing, LIU Juanjuan, ZHANG Yan, et al. Eukaryotic initiating factor eIF4E is targeted by EBVencoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma[J]. Virus Genes, 2021, 57(4): 358-368.
[16] PARK M C, KIM H, CHOI H, et al. Epstein-Barr virus miR-BART1-3p regulates the miR-17-92 cluster by targeting E2F3[J]. International Journal of Molecular Sciences, 2021, 22(20): 10936.
[17] CHOY E Y, SIU K L, KOK K H, et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival[J]. Journal of Experimental Medicine, 2008, 205(11): 2551-2560.
[18] SHINOZAKI-USHIKU A, KUNITA A, ISOGAI M, et al. Profiling of virus-encoded microRNAs in epsteinbarr virus-associated gastric carcinoma and their roles in gastric carcinogenesis[J]. Journal of Virology, 2015, 89(10): 5581-5591.
[19] CHOI H, LEE H, KIM S R, et al. Epstein-Barr virusencoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE[J]. Journal of Virology, 2013, 87(14): 8135-8144.
[20] 张金刚, 齐普良, 吴刚, 等．miR-505-3p 对胃癌细胞增殖、克隆形成及迁移、侵袭的影响及机制研究[J].现代检验医学杂志, 2022, 37(4)：69-74, 153. ZHANG Jingang, QI Puliang, WU Gang, et al. Effect and mechanism of miR-505-3p on proliferation, clone formation, migration and invasion of gastric cancer cells[J]. Journal of Modern Laboratory Medicine, 2022, 37(4): 69-74, 153.
[21] 郭殿华, 程芃, 陈卿奇, 等. 下调miR-572 抑制人胃癌细胞株凋亡、迁移和侵袭机制的实验研究[J]．现代检验医学杂志, 2022, 37(3): 157-161. GUO Dianhua, CHENG Peng, CHEN Qingqi, et al. Study on the mechanism of down-regulation of miR-572 in inhibiting apoptosis, migration and invasion of human gastric cancer cell lines[J]. Journal of Modern Laboratory Medicine, 2022, 37(3): 157-161.
[22] XU Xiangqian, DANG Zhongqin, ZHANG Junping, et al. The miRNA, miR-125b, inhibited invasion and metastasis of gastric-cancer cells by triggering the STAT3 signaling pathway [J]. Cancer Manag Res, 2020, 12: 8569-8580.
[23] XU Xiaodong, XIA Yingjie, MA Jie, et al. Upregulation of miRNA-301a-3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF-κB signaling[J]. International Journal of Oncology, 2020, 57(2): 522-532.
[24] LUO Yin, LIU Yitong, WANG Chengkun, et al. Signaling pathways of EBV-induced oncogenesis[J].Cancer Cell International, 2021, 21(1): 93.
[25] ZHOU Yang, XU Jiang, LUO Haichang, et al. Wnt signaling pathway in cancer immunotherapy [J]. Cancer Letters, 2022, 525: 84-96.
[26] DONG Min, GONG Liping, CHEN Jianning, et al. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway[J]. Cellular Oncology (Dordrecht), 2020, 43(5): 901-913.
[27] YU Hui, LIN Liangbin, ZHANG Zhiqiang, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduction and Targeted Therapy, 2020, 5(1): 209.
[28] ZHAO Zhenzhen, LIU Wen, LIU Jincheng, et al. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer[J]. Journal of Medical Virology, 2017, 89(10): 1844-1851.
[29] TSAI C Y, LIU Yuyin, LIU Kenghao, et al. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells[J]. Journal of Gastroenterology and Hepatology, 2017, 32(1): 82-91.
[30] LI Jun, ZHANG Yan, LIU Juanjuan, et al. EBV-miRBART12 inhibits cell migration and proliferation by targeting Snail expression in EBV-associated gastric cancer[J]. Archives of Virology, 2021, 166(5): 1313-1323.
[31] WU Yingfen, WANG Dan, WEI Fang, et al. EBVmiR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1[J]. FASEB Journal, 2020, 34(12): 16205-16223.
[32] HE Baoyu, LI Weiming, WU Yingfen, et al. EpsteinBarr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103[J]. Cell Death Dis, 2016, 7(9): e2353.
[33] WANG Dan, ZENG Zhao-yang, ZHANG Shanshan, et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis[J]. FASEB Journal, 2020, 34(6): 8012-8027.
[34] SASAKI S, NISHIKAWA J, SAKAI K, et al. EBVassociated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions[J]. Gastric Cancer, 2019, 22(3): 486-496.
[35] WANG Jie, GE Junshang, WANG Yian, et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1[J]. Nature Communications, 2022, 13(1): 866.
[36] YOON C J, CHANG M S, KIM D H, et al. Epstein– Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas[J].Gastric Cancer, 2020, 23(5): 780-795.
[37] ZENG Xi, WANG Haoying, BAI Suyang, et al. The roles of microRNAs in multidrug-resistance mechanisms in gastric cancer[J]. Current Molecular Medicine, 2020, 20(9): 667-674.
[38] LIU Ying, AO Xiang, JI Guoqiang, et al. Mechanisms of action and clinical implications of microRNAs in the drug resistance of gastric cancer [J]. Front Oncol, 2021, 11: 768918.
[39] KIM H, CHOI H, LEE S K. Epstein-Barr virus miRBART20-5p regulates cell proliferation and apoptosis by targeting BAD[J]. Cancer Letters, 2015, 356(2 Pt B): 733-742.
[40] CHOI H, LEE S K. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU[J]. Archives of Virology, 2017, 162(2): 369-377.
[41] MURATA T, SUGIMOTO A, INAGAKI T, et al. Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation[J]. Viruses, 2021, 13(12): 2344.
[42] KIM H, CHOI H, LEE S K. Epstein-Barr virus microRNA miR-BART20-5p suppresses lytic induction by inhibiting BAD-Mediated caspase-3-Dependent apoptosis[J]. Journal of Virology, 2015, 90(3): 1359-1368.
[43] ZHANG Yan, ZHANG Wen, LIU Wen, et al. Epstein-Barr virus miRNA-BART16 modulates cell proliferation by targeting LMP1 [J]. Virus Research, 2018, 256: 38-44.
[44] ZHOU Xiaohan, LIN Yanling, CHEN Yuting, et al. Epstein-Barr virus(EBV)encoded microRNA BART8-3p drives radioresistance-associated metastasis in nasopharyngeal carcinoma[J]. Journal of Cellular Physiology, 2021, 236(9): 6457-6471.
[45] HUANG Jing, QIN You, YANG Chensu, et al. Downregulation of ABI2 expression by EBV-miRBART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling[J]. Aging, 2020, 12(1): 340-358.
相似文献/References:
[1]张玲,刘杰,王臣玉,等.EB 病毒Rta 优势表位抗原的克隆表达及在应用ELISA 诊断鼻咽癌中的价值[J].现代检验医学杂志,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
ZHANG Ling,LIU Jie,WANG Chen-yu,et al.Cloning and Expression of Dominant Epitope Antigen of Epstein-Barr
Virus Rta Protein and Its Application in the Diagnosis of Nasopharyngeal
Carcinoma by ELISA[J].Journal of Modern Laboratory Medicine,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
[2]樊春荔,何燕娟.缺血性脑卒中和短暂性脑缺血发作患者血清miR-23b-3p 水平变化的比较研究[J].现代检验医学杂志,2020,35(05):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]
FAN Chun-li,HE Yan-juan.Altered Levels of Serum miR-23b-3p in Patients with Ischemic Stroke and
Transient Ischemic Attack[J].Journal of Modern Laboratory Medicine,2020,35(05):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]
[3]邰国梅,郭 京,王高仁.胸部放疗患者血浆外泌体中miR-7-5p与miR-17-5p的表达及临床意义[J].现代检验医学杂志,2021,36(04):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
TAI Guo-mei,GUO Jing,WANG Gao-ren.Expression and Clinical Significance of miR-7-5p and miR-17-5p in PlasmaExosomes of Patients with Thoracic Radiotherapy[J].Journal of Modern Laboratory Medicine,2021,36(05):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
[4]沈伟兴a,汤佳瑾b,傅 鹏a.2型糖尿病肾病患者外周血 microRNA-155水平与肾小球滤过率的相关性研究[J].现代检验医学杂志,2022,37(01):12.[doi:10.3969/j.issn.1671-7414.2022.01.003]
SHEN Wei-xinga,TANG Jia-jinb,FU Penga.Correlation between microRNA-155 Level in Peripheral Blood and Glomerular Filtration Rate in Patients with Type 2 DiabeticNephropathy[J].Journal of Modern Laboratory Medicine,2022,37(05):12.[doi:10.3969/j.issn.1671-7414.2022.01.003]
[5]韩雪娇,刘红红,邢宁宁,等.支气管扩张伴支气管哮喘患者血清中microRNA-146水平表达与肺功能相关性分析[J].现代检验医学杂志,2022,37(02):100.[doi:10.3969/j.issn.1671-7414.2022.02.021]
HAN Xue-jiao,LIU Hong-hong,XING Ning-ning,et al.Correlation Analysis between the Expression Level of micro RNA-146 in Serum and Lung Function in Patients with Bronchiectasis and Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2022,37(05):100.[doi:10.3969/j.issn.1671-7414.2022.02.021]
[6]张玲玲,张小霞,於潇潇,等.非小细胞肺癌患者血浆miR-520f，miR-143-3p表达与病理特征和预后的相关性研究[J].现代检验医学杂志,2022,37(03):69.[doi:10.3969/j.issn.1671-7414.2022.03.014]
ZHANG Ling-ling,ZHANG Xiao-xia,YU Xiao-xiao,et al.Correlation Study on Plasma miR-520f and miR-143-3p Expression with Pathological Features and Prognosis in Patients with Non-small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2022,37(05):69.[doi:10.3969/j.issn.1671-7414.2022.03.014]
[7]黄 英,陈 兰,周英艳,等.急性主动脉夹层患者血浆miR-30a及D-二聚体水平检测对临床预后判断价值[J].现代检验医学杂志,2022,37(03):187.[doi:10.3969/j.issn.1671-7414.2022.03.039]
HUANG Ying,CHEN Lan,ZHOU Ying-yan,et al.Clinical Prognostic Value of Plasma miR-30a and D-dimer Levels in Patients with Acute Aortic Dissection[J].Journal of Modern Laboratory Medicine,2022,37(05):187.[doi:10.3969/j.issn.1671-7414.2022.03.039]
[8]王 路,叶 莎,韩 霞,等.循环外泌体miRNA 检测对肝细胞癌临床诊断效能的Meta 分析[J].现代检验医学杂志,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
WANG Lu,YE Sha,HAN Xia,et al.Meta-Analysis of the Diagnostic Value of Circulating Exosomes miRNA Detection for Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(05):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
[9]韩 岳,左积文,陈丽丽,等.蛛网膜下腔出血患者不同神经功能恢复结局之间microRNAs 表达差异的meta 分析[J].现代检验医学杂志,2023,38(04):131.[doi:10.3969/j.issn.1671-7414.2023.04.024]
HAN Yue,ZUO Jiwen,CHEN Lili,et al.Meta-analysis of Differential microRNA Expression between Different Neurological Recovery Outcomes in Patients with Subarachnoid Hemorrhage[J].Journal of Modern Laboratory Medicine,2023,38(05):131.[doi:10.3969/j.issn.1671-7414.2023.04.024]
[10]沈开元a,曲晓力a,代小丽b,等.卵巢功能减退患者卵泡液外泌体差异表达miRNA 筛选及生物学功能分析[J].现代检验医学杂志,2023,38(05):17.[doi:10.3969/j.issn.1671-7414.2023.05.004]
SHEN Kaiyuana,QU Xiaolia,DAI Xiaolib,et al.Screening and Biological Function Analysis of Follicular Fluid-derived Exosomes Differentially Expressed miRNA in Patients with Diminished Ovarian Reserve[J].Journal of Modern Laboratory Medicine,2023,38(05):17.[doi:10.3969/j.issn.1671-7414.2023.05.004]